These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18684274)

  • 21. [Role of right heart failure in cardiac resynchronization].
    Neuss M; Schau T; Butter C
    Herzschrittmacherther Elektrophysiol; 2008 Dec; 19 Suppl 1():44-51. PubMed ID: 19169734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy.
    Mangiavacchi M; Gasparini M; Genovese S; Pini D; Klersy C; Bragato R; Andreuzzi B; Municinò A; Regoli F; Galimberti P; Ceriotti C; Gronda E
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1425-32. PubMed ID: 18950300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pressure-volume loop analysis during implantation of biventricular pacemaker/cardiac resynchronization therapy device to optimize right and left ventricular pacing sites.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Vos DH; Elvan A; Ramdat Misier AR; Beukema WP; Steendijk P; van Hemel NM
    Eur Heart J; 2009 Apr; 30(7):797-804. PubMed ID: 19202156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biventricular pacing in patients with right ventricular pacing-induced heart failure.
    Witte KK; Parker JD
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):E12. PubMed ID: 17212593
    [No Abstract]   [Full Text] [Related]  

  • 25. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
    Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
    Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimizing right ventricular pacing: a new paradigm for cardiac pacing in sinus node dysfunction.
    Sweeney MO
    Am Heart J; 2007 Apr; 153(4 Suppl):34-43. PubMed ID: 17394901
    [No Abstract]   [Full Text] [Related]  

  • 27. Right ventricular apical pacing: the unwanted model of cardiac stimulation?
    Pachón Mateos JC; Pachón Mateos EI; Pachón Mateos JC
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):789-99. PubMed ID: 19589115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Getting the most out of life.
    Schwartzman D
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1167-8. PubMed ID: 18631267
    [No Abstract]   [Full Text] [Related]  

  • 30. Early left ventricular lead dislodgement related to hyperpnea respiration.
    Chan JY; Fung JW; Yu CM
    Pacing Clin Electrophysiol; 2006 Apr; 29(4):425-6. PubMed ID: 16650273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac resynchronization therapy: the more pacing sites, the better the outcome?
    Auricchio A; Prinzen FW
    J Am Coll Cardiol; 2008 Apr; 51(15):1463-5. PubMed ID: 18402901
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiac resynchronization therapy: relevance of right ventricular function evaluation.
    Delgado V; Bax JJ
    Europace; 2010 Mar; 12(3):311-2. PubMed ID: 20173209
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
    Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
    Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upgrading pacing generators in the era of biventricular pacing.
    Kaye GC
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):689-90. PubMed ID: 16884502
    [No Abstract]   [Full Text] [Related]  

  • 35. Early cardiac resynchronization therapy and reverse remodeling in patients with mild heart failure: is it time?
    Francis GS; Tang WH
    Circulation; 2009 Nov; 120(19):1845-6. PubMed ID: 19858411
    [No Abstract]   [Full Text] [Related]  

  • 36. [Is resynchronization therapy necessary when optimizing right ventricular stimulation?].
    Fröhlig G
    Herzschrittmacherther Elektrophysiol; 2008 Dec; 19 Suppl 1():25-37. PubMed ID: 19169732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of left vs. right ventricular pacing on left ventricular remodelling.
    Bildirici U; Vural A; Agacdiken A; Sahin T; Celikyurt U; Kiliç T; Ural D
    Europace; 2008 Dec; 10(12):1387-91. PubMed ID: 19022835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dose response for cardiac resynchronization therapy?
    Faddis MN
    J Am Coll Cardiol; 2009 Jan; 53(4):361-2. PubMed ID: 19161887
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.